News

Mr Incredible will not be taking part in this year's Randox Grand NationalCredit: Alan Crowhurst (Getty Images) The Sandy Thomson-trained Mr Incredible has been barred from participating in Saturday's ...
The British Horseracing Authority has offered clarification as to why the Sandy Thomson-trained Mr Incredible has been prevented from running in Saturday’s Randox Grand National. While the nine ...
Eli Lilly has reported promising Phase II results for lepodisiran ... The study demonstrated that the therapy significantly reduced Lp(a) by an average of 93.9%, with the highest tested dose of 400mg ...
Milquetoast Henry Limpet experiences his fondest wish and is transformed into a fish. As a talking fish he assists the US Navy in hunting German submarines during World War II.
OSLO - TotalEnergies (EPA:TTEF) SE (Paris:TTE) (LSE:TTE) (NYSE:TTE), along with its partners Equinor and Shell, has announced the Final Investment Decision (FID) for the second phase of the Northern ...
Heffernan’s appointment comes at a crucial time as Avalo advances its pipeline of targeted therapies, particularly its lead candidate, AVTX-009, which is in the Phase 2 LOTUS trial for the treatment ...
George Foreman, an icon, a prized fighter, and an indomitable spirit, closed his eyes to the world on March 21, 2025. The legacy he left in boxing and beyond will forever stand as a testament to a man ...
CENTENNIAL, Colo. - Westwater Resources, Inc. (NYSE American: WWR), a company specializing in energy technology and the development of battery-grade natural graphite, has reported securing contracts ...
In clinical development, Aptevo’s lead candidate, Mipletamig, is undergoing a Phase 1b/2 trial for frontline acute myeloid leukemia (AML) treatment, showing promising results, including a 100% ...
Ocugen plans to complete the Phase 1 trial in the latter half of 2025 and will provide updates on safety and efficacy throughout the year. The company is focused on addressing the unmet medical ...